Evidence map›Paper›PMID 32650272›Full record

ArticleEBioMedicine2020

Corrigendum to 'Cyclic AMP-Responsive element-binding protein (CREB) is critical in autoimmunity by promoting Th17 but inhibiting treg cell differentiation': [EBioMedicine 25 (2017) 165-174].

Xiaohu Wang, Lu Ni, Dehui Chang, Huiping Lu, Yu Jiang, Byung-Seok Kim, Aibo Wang, Xindong Liu, Bo Zhong, Xuexian Yang and 1 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in EBioMedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Xiaohu WangInstitute for Immunology and School of Medicine, Tsinghua University, Beijing 100084, China. Electronic address: wangxhu@tsinghua.edu.cn.
Lu NiInstitute for Immunology and School of Medicine, Tsinghua University, Beijing 100084, China.
Dehui ChangInstitute for Immunology and School of Medicine, Tsinghua University, Beijing 100084, China.
Huiping LuInstitute for Immunology and School of Medicine, Tsinghua University, Beijing 100084, China.
Yu JiangInstitute for Immunology and School of Medicine, Tsinghua University, Beijing 100084, China.
Byung-Seok KimDepartment of Immunology, M.D. Anderson Cancer Center, Houston, TX 77030, United States.
Aibo WangDepartment of Immunology, M.D. Anderson Cancer Center, Houston, TX 77030, United States.
Xindong LiuInstitute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University, Chongqing 400038, China.
Bo ZhongSchool of Life Sciences, Wuhan University, Wuhan 430072, China.
Xuexian YangDepartment of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, NM, United States.
Chen DongInstitute for Immunology and School of Medicine, Tsinghua University, Beijing 100084, China. Electronic address: chendong@tsinghua.edu.cn.
Tsinghua University · CNThe University of Texas MD Anderson Cancer Center · USArmy Medical University · CNUniversity of New Mexico · USWuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32650272
PMCPMC7341339
OpenAlexW3041386876

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.